|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000024154 |
| Receipt No. | R000027812 |
| Scientific Title | Phase II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel therapy for patients with borderline resectable pancreatic cancer. |
| Date of disclosure of the study information | 2016/10/01 |
| Last modified on | 2017/07/01 17:27:12 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2016/09/25 11:03:07 | ||
| 2 | Update | 2016/09/27 21:02:35 | Institutions |
|
| 3 | Update | 2016/11/15 09:18:44 | Organization Organization Organization Division Nationality of Funding Organization Nationality of Funding Organization |
|
| 4 | Update | 2017/01/10 20:59:28 | Recruitment status |
|
| 5 | Update | 2017/07/01 17:27:12 | Recruitment status |
